NewReferencesToProblem: verschil tussen versies
(→Realisation) |
(→Realisation) |
||
| (4 tussenliggende versies door dezelfde gebruiker niet weergegeven) | |||
| Regel 18: | Regel 18: | ||
|Current reference | |Current reference | ||
|Replacement reference(s) | |Replacement reference(s) | ||
| − | | | + | |style="text-align:center;" |Current information model |
| − | |New information model | + | |style="text-align:center;" |New information model |
|-style="vertical-align: top;" | |-style="vertical-align: top;" | ||
|width="20%" |[[Admission-v2.0(2024EN)| Admission]] | |width="20%" |[[Admission-v2.0(2024EN)| Admission]] | ||
| Regel 25: | Regel 25: | ||
|width="20%" |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]] | |width="20%" |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]] | ||
|style="text-align:center;" |[[Bestand:Admission-v2.0Model(2024EN).png | 150px |link=]]<br>[[Media:Admission-v2.0Model(2024EN).png | full-size]] | |style="text-align:center;" |[[Bestand:Admission-v2.0Model(2024EN).png | 150px |link=]]<br>[[Media:Admission-v2.0Model(2024EN).png | full-size]] | ||
| − | | | + | |style="text-align:center;" |[[Bestand:Admission-v2.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:Admission-v2.0Model(2024EN)_Nieuw.png | full-size]] |
| + | |||
|-style="vertical-align: top;" | |-style="vertical-align: top;" | ||
|[[AdvanceDirective-v4.3(2024EN)| AdvanceDirective]] | |[[AdvanceDirective-v4.3(2024EN)| AdvanceDirective]] | ||
| Regel 31: | Regel 32: | ||
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]] | |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]] | ||
|style="text-align:center;" |[[Bestand:AdvanceDirective-v4.3Model(2024EN).png | 150px |link=]]<br>[[Media:AdvanceDirective-v4.3Model(2024EN).png | full-size]] | |style="text-align:center;" |[[Bestand:AdvanceDirective-v4.3Model(2024EN).png | 150px |link=]]<br>[[Media:AdvanceDirective-v4.3Model(2024EN).png | full-size]] | ||
| − | | | + | |style="text-align:center;" |[[Bestand:AdvanceDirective-v4.3Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:AdvanceDirective-v4.3Model(2024EN)_Nieuw.png | full-size]] |
|-style="vertical-align: top;" | |-style="vertical-align: top;" | ||
|[[Alert-v4.2(2024EN)| Alert]] | |[[Alert-v4.2(2024EN)| Alert]] | ||
| Regel 37: | Regel 38: | ||
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]] [[#Notes | <sup>1</sup>]] | |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]] [[#Notes | <sup>1</sup>]] | ||
|style="text-align:center;" | [[Bestand:Alert-v4.2Model(2024EN).png | 150px |link=]]<br>[[Media:Alert-v4.2Model(2024EN).png | full-size]] | |style="text-align:center;" | [[Bestand:Alert-v4.2Model(2024EN).png | 150px |link=]]<br>[[Media:Alert-v4.2Model(2024EN).png | full-size]] | ||
| − | | | + | |style="text-align:center;" | [[Bestand:Alert-v4.2Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:Alert-v4.2Model(2024EN)_Nieuw.png | full-size]] |
|-style="vertical-align: top;" | |-style="vertical-align: top;" | ||
|[[CareAgreement-v1.1(2024EN)| CareAgreement]] | |[[CareAgreement-v1.1(2024EN)| CareAgreement]] | ||
| Regel 43: | Regel 44: | ||
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]] | |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]] | ||
|style="text-align:center;" |[[Bestand:CareAgreement-v1.1Model(2024EN).png | 150px |link=]]<br>[[Media:CareAgreement-v1.1Model(2024EN).png | full-size]] | |style="text-align:center;" |[[Bestand:CareAgreement-v1.1Model(2024EN).png | 150px |link=]]<br>[[Media:CareAgreement-v1.1Model(2024EN).png | full-size]] | ||
| − | | | + | |style="text-align:center;" |[[Bestand:CareAgreement-v1.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:CareAgreement-v1.1Model(2024EN)_Nieuw.png | full-size]] |
|-style="vertical-align: top;" | |-style="vertical-align: top;" | ||
|[[CareTeam-v1.0.1(2024EN)| CareTeam]] | |[[CareTeam-v1.0.1(2024EN)| CareTeam]] | ||
| Regel 49: | Regel 50: | ||
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]] | |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]] | ||
|style="text-align:center;" |[[Bestand:CareTeam-v1.0.1Model(2024EN).png | 150px |link=]]<br>[[Media:CareTeam-v1.0.1Model(2024EN).png | full-size]] | |style="text-align:center;" |[[Bestand:CareTeam-v1.0.1Model(2024EN).png | 150px |link=]]<br>[[Media:CareTeam-v1.0.1Model(2024EN).png | full-size]] | ||
| − | | | + | |style="text-align:center;" |[[Bestand:CareTeam-v1.0.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:CareTeam-v1.0.1Model(2024EN)_Nieuw.png | full-size]] |
|-style="vertical-align: top;" | |-style="vertical-align: top;" | ||
|[[Encounter-v6.0(2024EN)| Encounter]] | |[[Encounter-v6.0(2024EN)| Encounter]] | ||
| Regel 55: | Regel 56: | ||
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]] | |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]] | ||
|style="text-align:center;" |[[Bestand:Encounter-v6.0Model(2024EN).png | 150px |link=]]<br>[[Media:Encounter-v6.0Model(2024EN).png | full-size]] | |style="text-align:center;" |[[Bestand:Encounter-v6.0Model(2024EN).png | 150px |link=]]<br>[[Media:Encounter-v6.0Model(2024EN).png | full-size]] | ||
| − | | | + | |style="text-align:center;" |[[Bestand:Encounter-v6.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:Encounter-v6.0Model(2024EN)_Nieuw.png | full-size]] |
|-style="vertical-align: top;" | |-style="vertical-align: top;" | ||
|[[EpisodeOfCare-v1.0(2024EN)| EpisodeOfCare]] | |[[EpisodeOfCare-v1.0(2024EN)| EpisodeOfCare]] | ||
| Regel 61: | Regel 62: | ||
|[[Condition-v1.0(2024EN) | Condition]] [[#Notes | <sup>2</sup>]] | |[[Condition-v1.0(2024EN) | Condition]] [[#Notes | <sup>2</sup>]] | ||
|style="text-align:center;" |[[Bestand:EpisodeOfCare-v1.0Model(2024EN).png | 150px |link=]]<br>[[Media:EpisodeOfCare-v1.0Model(2024EN).png | full-size]] | |style="text-align:center;" |[[Bestand:EpisodeOfCare-v1.0Model(2024EN).png | 150px |link=]]<br>[[Media:EpisodeOfCare-v1.0Model(2024EN).png | full-size]] | ||
| − | | | + | |style="text-align:center;" |[[Bestand:EpisodeOfCare-v1.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:EpisodeOfCare-v1.0Model(2024EN)_Nieuw.png | full-size]] |
|-style="vertical-align: top;" | |-style="vertical-align: top;" | ||
|[[FamilyHistory-v4.0(2024EN)| FamilyHistory]] | |[[FamilyHistory-v4.0(2024EN)| FamilyHistory]] | ||
| Regel 67: | Regel 68: | ||
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]] | |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]] | ||
|style="text-align:center;" |[[Bestand:FamilyHistory-v4.0Model(2024EN).png | 150px |link=]]<br>[[Media:FamilyHistory-v4.0Model(2024EN).png | full-size]] | |style="text-align:center;" |[[Bestand:FamilyHistory-v4.0Model(2024EN).png | 150px |link=]]<br>[[Media:FamilyHistory-v4.0Model(2024EN).png | full-size]] | ||
| − | | | + | |style="text-align:center;" |[[Bestand:FamilyHistory-v4.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:FamilyHistory-v4.0Model(2024EN)_Nieuw.png | full-size]] |
|-style="vertical-align: top;" | |-style="vertical-align: top;" | ||
|[[MedicalDevice-v4.0(2024EN)| MedicalDevice]] | |[[MedicalDevice-v4.0(2024EN)| MedicalDevice]] | ||
| Regel 73: | Regel 74: | ||
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]] | |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]] | ||
|style="text-align:center;" |[[Bestand:MedicalDevice-v4.0Model(2024EN).png | 150px |link=]]<br>[[Media:MedicalDevice-v4.0Model(2024EN).png | full-size]] | |style="text-align:center;" |[[Bestand:MedicalDevice-v4.0Model(2024EN).png | 150px |link=]]<br>[[Media:MedicalDevice-v4.0Model(2024EN).png | full-size]] | ||
| − | | | + | |style="text-align:center;" |[[Bestand:MedicalDevice-v4.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:MedicalDevice-v4.0Model(2024EN)_Nieuw.png | full-size]] |
|-style="vertical-align: top;" | |-style="vertical-align: top;" | ||
|[[MedicationAgreement-v3.0(2024EN)| MedicationAgreement]] | |[[MedicationAgreement-v3.0(2024EN)| MedicationAgreement]] | ||
| Regel 79: | Regel 80: | ||
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]] | |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]] | ||
|style="text-align:center;" |[[Bestand:MedicationAgreement-v3.0Model(2024EN).png | 150px |link=]]<br>[[Media:MedicationAgreement-v3.0Model(2024EN).png | full-size]] | |style="text-align:center;" |[[Bestand:MedicationAgreement-v3.0Model(2024EN).png | 150px |link=]]<br>[[Media:MedicationAgreement-v3.0Model(2024EN).png | full-size]] | ||
| − | | | + | |style="text-align:center;" |[[Bestand:MedicationAgreement-v3.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:MedicationAgreement-v3.0Model(2024EN)_Nieuw.png | full-size]] |
|-style="vertical-align: top;" | |-style="vertical-align: top;" | ||
|[[MultidisciplinaryTeamMeeting-v2.0(2024EN)| MultidisciplinaryTeamMeeting]] | |[[MultidisciplinaryTeamMeeting-v2.0(2024EN)| MultidisciplinaryTeamMeeting]] | ||
| Regel 85: | Regel 86: | ||
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]] | |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]] | ||
|style="text-align:center;" |[[Bestand:MultidisciplinaryTeamMeeting-v2.0Model(2024EN).png | 150px |link=]]<br>[[Media:MultidisciplinaryTeamMeeting-v2.0Model(2024EN).png | full-size]] | |style="text-align:center;" |[[Bestand:MultidisciplinaryTeamMeeting-v2.0Model(2024EN).png | 150px |link=]]<br>[[Media:MultidisciplinaryTeamMeeting-v2.0Model(2024EN).png | full-size]] | ||
| − | | | + | |style="text-align:center;" |[[Bestand:MultidisciplinaryTeamMeeting-v2.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:MultidisciplinaryTeamMeeting-v2.0Model(2024EN)_Nieuw.png | full-size]] |
|-style="vertical-align: top;" | |-style="vertical-align: top;" | ||
|[[NursingIntervention-v4.1(2024EN)| NursingIntervention]] | |[[NursingIntervention-v4.1(2024EN)| NursingIntervention]] | ||
| Regel 91: | Regel 92: | ||
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]] | |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]] | ||
|style="text-align:center;" |[[Bestand:NursingIntervention-v4.1Model(2024EN).png | 150px |link=]]<br>[[Media:NursingIntervention-v4.1Model(2024EN).png | full-size]] | |style="text-align:center;" |[[Bestand:NursingIntervention-v4.1Model(2024EN).png | 150px |link=]]<br>[[Media:NursingIntervention-v4.1Model(2024EN).png | full-size]] | ||
| − | | | + | |style="text-align:center;" |[[Bestand:NursingIntervention-v4.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:NursingIntervention-v4.1Model(2024EN)_Nieuw.png | full-size]] |
|-style="vertical-align: top;" | |-style="vertical-align: top;" | ||
|[[NutritionAdvice-v3.2.1(2024EN)| NutritionAdvice]] | |[[NutritionAdvice-v3.2.1(2024EN)| NutritionAdvice]] | ||
| Regel 97: | Regel 98: | ||
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]] | |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]] | ||
|style="text-align:center;" |[[Bestand:NutritionAdvice-v3.2.1Model(2024EN).png | 150px |link=]]<br>[[Media:NutritionAdvice-v3.2.1Model(2024EN).png | full-size]] | |style="text-align:center;" |[[Bestand:NutritionAdvice-v3.2.1Model(2024EN).png | 150px |link=]]<br>[[Media:NutritionAdvice-v3.2.1Model(2024EN).png | full-size]] | ||
| − | | | + | |style="text-align:center;" |[[Bestand:NutritionAdvice-v3.2.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:NutritionAdvice-v3.2.1Model(2024EN)_Nieuw.png | full-size]] |
|-style="vertical-align: top;" | |-style="vertical-align: top;" | ||
|[[Procedure-v5.4.1(2024EN)| Procedure]] | |[[Procedure-v5.4.1(2024EN)| Procedure]] | ||
|[[Problem-v4.7(2024EN)|Problem]] | |[[Problem-v4.7(2024EN)|Problem]] | ||
| − | |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]] | + | |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]] |
|style="text-align:center;" |[[Bestand:Procedure-v5.4.1Model(2024EN).png | 150px |link=]]<br>[[Media:Procedure-v5.4.1Model(2024EN).png | full-size]] | |style="text-align:center;" |[[Bestand:Procedure-v5.4.1Model(2024EN).png | 150px |link=]]<br>[[Media:Procedure-v5.4.1Model(2024EN).png | full-size]] | ||
| − | | | + | |style="text-align:center;" |[[Bestand:Procedure-v5.4.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:Procedure-v5.4.1Model(2024EN)_Nieuw.png | full-size]] |
|-style="vertical-align: top;" | |-style="vertical-align: top;" | ||
|[[Signaling-v2.0(2024EN)| Signaling]] | |[[Signaling-v2.0(2024EN)| Signaling]] | ||
| Regel 115: | Regel 116: | ||
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]] | |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]] | ||
|style="text-align:center;" |[[Bestand:SkinDisorder-v3.4Model(2024EN).png | 150px |link=]]<br>[[Media:SkinDisorder-v3.4Model(2024EN).png | full-size]] | |style="text-align:center;" |[[Bestand:SkinDisorder-v3.4Model(2024EN).png | 150px |link=]]<br>[[Media:SkinDisorder-v3.4Model(2024EN).png | full-size]] | ||
| − | | | + | |style="text-align:center;" |[[Bestand:SkinDisorder-v3.4Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:SkinDisorder-v3.4Model(2024EN)_Nieuw.png | full-size]] |
|-style="vertical-align: top;" | |-style="vertical-align: top;" | ||
|[[TreatmentObjective-v3.2.1(2024EN)| TreatmentObjective]] | |[[TreatmentObjective-v3.2.1(2024EN)| TreatmentObjective]] | ||
Huidige versie van 9 jul 2024 om 11:24
Reason
Upon acceptance of the revision of the HCIM Problem, in release 2024 the HCIM Problem will disappear. This means that HCIMs currently referring to the HCIM Problem will have to be modified.
The HCIM Problem represented multiple concepts and these have been modelled in separate HCIMs after the revision of the HCIM Problem.
Realisation
The following HCIMs are eligable to replace the reference to the HCIM Problem:
Depending on the nature of the concept of a HCIM currently referring to Problem, replacing the reference to the HCIM Problem requires a reference to one or more of the above HCIMs.
The table below shows, for each HCIM with a current reference to the HCIM Problem, which reference(s) will replace it.
Notes
1 HypersensitivityIntolerance reference should only be used when it is not medication related, as that is what the HCIM SurveillanceDecision is intended for.
2 An EpisodeOfCare relates to a condition that a health professional is following.
